CD14 impairs host defense against gram-negative sepsis caused by Burkholderia pseudomallei in mice

Journal of Infectious Diseases

Volumn 198, Issue 9, 2008, Pages 1388-1397

  Wiersinga, W Joost ^a   De Vos, Alex F ^a   Wieland, Catharina W ^a   Leendertse, Masja ^a   Roelofs, Joris J T H ^a   Van Der Poll, Tom ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN FUNCTION; ARTICLE; BACTERIAL GROWTH; BURKHOLDERIA PSEUDOMALLEI; CONTROLLED STUDY; GRAM NEGATIVE SEPSIS; HOST RESISTANCE; LETHALITY; LEUKOCYTE; MELIOIDOSIS; MOUSE; NEUTROPHIL; NONHUMAN; ORGAN INJURY; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; ANTIGENS, CD14; BURKHOLDERIA PSEUDOMALLEI; FEMALE; KIDNEY; LIVER; LUNG; MACROPHAGES; MALE; MELIOIDOSIS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; PHAGOCYTOSIS; PNEUMONIA, BACTERIAL; SEPSIS;

EID: 54249134299     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/592220     Document Type: Article

References (51)

1. White NJ. Melioidosis. Lancet 2003; 361:1715-22.
2. Wiersinga WJ, van der Poll T, White NJ, Day NP, Peacock SJ. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat Rev Microbiol 2006; 4:272-82.
3. Currie BJ. Melioidosis: an important cause of pneumonia in residents of and travellers returned from endemic regions. Eur Respir J 2003; 22: 542-50.
4. Wiersinga WJ, Wieland CW, van der Windt GJ, et al. Endogenous interleukin-18 improves the early antimicrobial host response in severe melioidosis. Infect Immun 2007; 75:3739-46.
5. Wiersinga WJ, Veer CT, Wieland CW, et al. Expression profile and function of triggering receptor expressed on myeloid cells-1 during melioidosis. J Infect Dis 2007; 196:1707-16.
6. Wiersinga WJ, Wieland CW, Dessing MC, et al. Toll-like receptor 2 impairs host defense in gram-negative sepsis caused by Burkholderia pseudomallei (melioidosis). PLoS Med 2007; 4:e248.
7. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124:783-801.
8. Beutler B, Jiang Z, Georgel P, et al. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu Rev Immunol 2006; 24:353-89.
9. Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 2007; 7:179-90.
10. Miyake K. Innate recognition of lipopolysaccharide by Toll-like receptor 4-MD-2. Trends Microbiol 2004; 12:186-92.
11. Bazil V, Strominger JL. Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol 1991; 147:1567-74.
12. Landmann R, Muller B, Zimmerli W. CD14, new aspects of ligand and signal diversity. Microbes Infect 2000; 2:295-304.
13. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249:1431-3.
14. Kusunoki T, Hailman E, Juan TS, Lichenstein HS, Wright SD. Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses. J Exp Med 1995; 182:1673-82.
15. Cleveland MG, Gorham JD, Murphy TL, Tuomanen E, Murphy KM. Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway. Infect Immun 1996; 64:1906-12.
16. Leturcq DJ, Moriarty AM, Talbott G, Winn RK, Martin TR, Ulevitch RJ. Antibodies against CD14 protect primates from endotoxin-induced shock. J Clin Invest 1996; 98:1533-8.
17. Schimke J, Mathison J, Morgiewicz J, Ulevitch RJ. Anti-CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin. Proc Natl Acad Sci U S A 1998; 95:13875-80.
18. Tasaka S, Ishizaka A, Yamada W, et al. Effect of CD14 blockade on endotoxin-induced acute lung injury in mice. Am J Respir Cell Mol Biol 2003; 29:252-8.
19. Spek CA, Verbon A, Aberson H, et al. Treatment with an anti-CD14 monoclonal antibody delays and inhibits lipopolysaccharide-induced gene expression in humans in vivo. J Clin Immunol 2003;23:132-40.
20. Le Roy D, Di Padova F, Tees R, et al. Monoclonal antibodies to murine lipopolysaccharide (LPS)-binding protein (LBP) protect mice from lethal endotoxemia by blocking either the binding of LPS to LBP or the presentation of LPS/LBP complexes to CD14. J Immunol 1999; 162:7454-60.
21. Beutler B, Rietschel ET. Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 2003; 3:169-76.
22. Frevert CW, Matute-Bello G, Skerrett SJ, et al. Effect of CD14 blockade in rabbits with Escherichia coli pneumonia and sepsis. J Immunol 2000; 164:5439-45.
23. Opal SM, Palardy JE, Parejo N, Jasman RL. Effect of anti-CD14 monoclonal antibody on clearance of Escherichia coli bacteremia and endotoxemia. Crit Care Med 2003; 31:929-32.
24. Knapp S, Wieland CW, Florquin S, et al. Differential roles of CD14 and Toll-like receptors 4 and 2 in murine Acinetobacter pneumonia. Am J Respir Crit Care Med 2006; 173:122-9.
25. Wieland CW, Florquin S, Maris NA, et al. The MyD88-dependent, but not the MyD88-independent, pathway of TLR4 signaling is important in clearing nontypeable Haemophilus influenzae from the mouse lung. J Immunol 2005; 175:6042-9.
26. Dessing MC, Knapp S, Florquin S, de Vos AF, van der Poll T. CD14 facilitates invasive respiratory tract infection by Streptococcus pneumoniae. Am J Respir Crit Care Med 2007; 175:604-11.
27. Knapp S, Matt U, Leitinger N, van der Poll T. Oxidized phospholipids inhibit phagocytosis and impair outcome in gram-negative sepsis in vivo. J Immunol 2007; 178:993-1001.
28. DeShazer D. Genomic diversity of Burkholderia pseudomallei clinical isolates: subtractive hybridization reveals a Burkholderia mallei-specific prophage in B. pseudomallei 1026b. J Bacteriol 2004; 186:3938-50.
29. Jeddeloh JA, Fritz DL, Waag DM, Hartings JM, Andrews GP. Biodefense-driven murine model of pneumonic melioidosis. Infect Immun 2003; 71:584-7.
30. Rijneveld AW, Levi M, Florquin S, Speelman P, Carmeliet P, van Der Poll T. Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia. J Immunol 2002; 168:3507-11.
31. Wan CP, Park CS, Lau BH. A rapid and simple microfluorometric phagocytosis assay. J Immunol Methods 1993; 162:1-7.
32. Su SH, Chen HI, Jen CJ. Severe exercise enhances phagocytosis by murine bronchoalveolar macrophages. J Leukoc Biol 2001; 69:75-80.
33. Weijer S, Sewnath ME, de Vos AF, et al. Interleukin-18 facilitates the early antimicrobial host response to Escherichia coli peritonitis. Infect Immun 2003; 71:5488-97.
34. Blander JM, Medzhitov R. Regulation of phagosome maturation by signals from toll-like receptors. Science 2004; 304:1014-8.
35. Katz SS, Chen K, Chen S, Doerfler ME, Elsbach P, Weiss J. Potent CD14-mediated signalling of human leukocytes by Escherichia coli can be mediated by interaction of whole bacteria and host cells without extensive prior release of endotoxin. Infect Immun 1996; 64:3592-600.
36. Strieter RM, Belperio JA, Keane MP. Cytokines in innate host defense in the lung. J Clin Invest 2002; 109:699-705.
37. Haziot A, Ferrero E, Kontgen F, et al. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 1996; 4:407-14.
38. Woltmann A, Gangloff SC, Bruch HP, et al. Reduced bacterial dissemination and liver injury in CD14-deficient mice following a chronic abscess-forming peritonitis induced by Bacteroides fragilis. Med Microbiol Immunol 1999; 187:149-56.
39. Carlet J, Cohen J, Calandra T, Opal SM, Masur H. Sepsis: time to reconsider the concept. Crit Care Med 2008; 36:964-6.
40. van der Poll T, Opal SM. Host-pathogen interactions in sepsis. Lancet Infect Dis 2008; 8:32-43.
41. Manukyan M, Triantafilou K, Triantafilou M, et al. Binding of lipopeptide to CD14 induces physical proximity of CD14, TLR2 and TLR1. Eur J Immunol 2005; 35:911-21.
42. Jones AL, Beveridge TJ, Woods DE. Intracellular survival of Burkholderia pseudomallei. Infect Immun 1996; 64:782-90.
43. Stevens MP, Wood MW, Taylor LA, et al. An Inv/Mxi-Spa-like type III protein secretion system in Burkholderia pseudomallei modulates intracellular behaviour of the pathogen. Mol Microbiol 2002; 46:649-59.
44. Letiembre M, Echchannaoui H, Bachmann P, et al. Toll-like receptor 2 deficiency delays pneumococcal phagocytosis and impairs oxidative killing by granulocytes. Infect Immun 2005; 73:8397-401.
45. Grunwald U, Fan X, Jack RS, et al. Monocytes can phagocytose gram-negative bacteria by a CD14-dependent mechanism. J Immunol 1996; 157:4119-25.
46. Verbon A, Dekkers PE, ten Hove T, et al. IC14, an anti-CD14 antibody, inhibits endotoxin-mediated symptoms and inflammatory responses in humans. J Immunol 2001; 166:3599-605.
47. Yates RM, Russell DG. Phagosome maturation proceeds independently of stimulation of Toll-like receptors 2 and 4. Immunity 2005; 23:409-17.
48. Russell DG, Yates RM. TLR signalling and phagosome maturation: an alternative viewpoint. Cell Microbiol 2007; 9:849-50.
49. Santanirand P, Harley VS, Dance DA, Drasar BS, Bancroft GJ. Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei. Infect Immun 1999; 67:3593-600.
50. Easton A, Haque A, Chu K, Lukaszewski R, Bancroft GJ. A critical role for neutrophils in resistance to experimental infection with Burkholderia pseudomallei. J Infect Dis 2007; 195:99-107.
51. Reinhart K, Gluck T, Ligtenberg J, et al. CD14 receptor occupancy in severe sepsis: results of a phase I clinical trial with a recombinant chimeric CD14 monoclonal antibody (IC14). Crit Care Med 2004; 32:1100-8.